ATONRA PARTNERS – Fate Therapeutics, Inc. Transaction History
ATONRA PARTNERS portfolio value:
$425,000
portfolio value
ATONRA PARTNERS quarter portfolio value change:
-9.56%
quarter
Fate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.71% | -528 shares | -58K | $22.41 | 18.94K |
| Q2 2022 | share | Decrease | -5.91% | -1.22K shares | -319K | $24.78 | 19.47K |
| Q1 2022 | share | Increase | +28.25% | 4.55K shares | -142K | $38.77 | 20.69K |
| Q4 2021 | share | Increase | +11.34% | 1.64K shares | 85K | $60.07 | 16.13K |
| Q3 2021 | share | Decrease | -37.56% | -8.71K shares | -1.15M | $59.27 | 14.49K |
| Q2 2021 | share | Increase | +6.15% | 1.34K shares | 211K | $86.79 | 23.21K |
| Q1 2021 | share | Decrease | -6.58% | -1.54K shares | -325K | $82.45 | 21.86K |
| Q4 2020 | share | Increase | 0.00% | 23.40K shares | 2.12M | $90.93 | 23.40K |